The clinical outcomes are complex and often involve multiple systems. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory tests and pathological evaluations.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnoses and treatment programs. In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions, adapting to timely schemes according to changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of carcinogenicity associated with diabetes. The platform serves a team of internationally authoritative experts in the field of genetic metabolism at home and abroad in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.